Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose study.
about
Clinical pharmacokinetics and pharmacodynamics of linagliptin.Linagliptin: A thorough Characterization beyond Its Clinical EfficacyEvaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers.Linagliptin for the treatment of type 2 diabetes (pharmacokinetic evaluation).Comparative clinical pharmacokinetics of dipeptidyl peptidase-4 inhibitors.Linagliptin: a review of its use in the management of type 2 diabetes mellitus.Clinical utility of the dipeptidyl peptidase-4 inhibitor linagliptin.The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation.DPP-4 inhibitors: focus on safety.Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus.Perspectives on variability in pharmacokinetics of an oral contraceptive product.Effect of empagliflozin on the steady-state pharmacokinetics of ethinylestradiol and levonorgestrel in healthy female volunteers.Clinical drug-drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P-glycoprotein.
P2860
Q34638128-D59EC24D-FA40-4CC5-971E-ABC65009BC80Q36636639-922DD722-CED0-4025-B02C-D58B253CBDB0Q37461886-E3AE8F7D-2CD0-4B22-AA00-9CF77F758D7FQ37948831-268B8F02-15F1-42BA-80DB-82D6CB84DB83Q38017726-312F1867-1A01-434B-86EA-F3ED06E35CE7Q38036742-94E55281-16F0-4EFF-BFE0-C4956F84013DQ38113093-4834E2B2-C622-4F87-8088-A22BB70C506EQ38205588-D7A83D50-4F6D-40C3-903F-A3586D71072CQ38263364-6115BC98-373D-437F-B292-605FDB44E6BDQ38285608-DEB7CE99-849F-474D-8F4E-CBADF3733EF2Q38546981-11CC6311-B3D0-439D-8280-3CCD7A41404AQ38913410-5639CE98-A951-4914-8E7E-1409DC1B2422Q44978773-FEB811C0-1633-416C-9EE6-4568EEE44E7EQ47832562-44889FF8-EBFA-4E53-82D0-03D9060609FB
P2860
Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Effect of multiple oral doses ...... sequence, multiple-dose study.
@en
Effect of multiple oral doses ...... sequence, multiple-dose study.
@nl
type
label
Effect of multiple oral doses ...... sequence, multiple-dose study.
@en
Effect of multiple oral doses ...... sequence, multiple-dose study.
@nl
prefLabel
Effect of multiple oral doses ...... sequence, multiple-dose study.
@en
Effect of multiple oral doses ...... sequence, multiple-dose study.
@nl
P2093
P2860
P50
P1476
Effect of multiple oral doses ...... -sequence, multiple-dose study
@en
P2093
Andreas Port
Hans-Juergen Woerle
Mario Iovino
Thomas Giessmann
Ulrike Graefe-Mody
P2860
P304
P356
10.2165/11590240-000000000-00000
P577
2011-01-01T00:00:00Z